Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaginal versus sublingual misoprostol for early first-trimester medical abortion
ChiCTR1900025763Phase 4Suspended
- Sponsor
- The University of Hong Kong-Shenzhen Hospital
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of mifepristone and misoprostol in pregnancy (2 arms), sponsored by The University of Hong Kong-Shenzhen Hospital. Primary endpoint: Complete abortion rate. Started Oct 2019; status: suspended.
02
Drugs
mifepristonemisoprostol
03
Conditions
pregnancy
Beyond the preview
Go deeper on ChiCTR1900025763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900025763.